Table 3.
Open in new tab

Changes in testosterone concentrations, complete blood count, and prostate specific antigen in hypogonadal men before (T0) and 6 months after starting testosterone replacement therapy (T1)

T0T1Absolute difference (median)P
Testosterone, nmol/L6.4 (2.6-8.7)16.0 (12.5-27.0)9.9<.0001
Hemoglobin, g/dL14.1 (1.1)15.1 (1.2)1.1<.0001
Hematocrit, %41.7 (3.1)44.6 (3.3)2.9<.0001
PSA, ng/mL0.55 (0.33-1.03)0.66 (0.50-1.27)0.17<.0001
T0T1Absolute difference (median)P
Testosterone, nmol/L6.4 (2.6-8.7)16.0 (12.5-27.0)9.9<.0001
Hemoglobin, g/dL14.1 (1.1)15.1 (1.2)1.1<.0001
Hematocrit, %41.7 (3.1)44.6 (3.3)2.9<.0001
PSA, ng/mL0.55 (0.33-1.03)0.66 (0.50-1.27)0.17<.0001

Results are reported as mean (SD) or median (IQR).

Abbreviation: PSA, prostate-specific antigen.

Table 3.
Open in new tab

Changes in testosterone concentrations, complete blood count, and prostate specific antigen in hypogonadal men before (T0) and 6 months after starting testosterone replacement therapy (T1)

T0T1Absolute difference (median)P
Testosterone, nmol/L6.4 (2.6-8.7)16.0 (12.5-27.0)9.9<.0001
Hemoglobin, g/dL14.1 (1.1)15.1 (1.2)1.1<.0001
Hematocrit, %41.7 (3.1)44.6 (3.3)2.9<.0001
PSA, ng/mL0.55 (0.33-1.03)0.66 (0.50-1.27)0.17<.0001
T0T1Absolute difference (median)P
Testosterone, nmol/L6.4 (2.6-8.7)16.0 (12.5-27.0)9.9<.0001
Hemoglobin, g/dL14.1 (1.1)15.1 (1.2)1.1<.0001
Hematocrit, %41.7 (3.1)44.6 (3.3)2.9<.0001
PSA, ng/mL0.55 (0.33-1.03)0.66 (0.50-1.27)0.17<.0001

Results are reported as mean (SD) or median (IQR).

Abbreviation: PSA, prostate-specific antigen.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close